BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21314764)

  • 1. Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study.
    Meini M; Moncini M; Cecconi D; Cellesi V; Biasci L; Simoni G; Ameglio M; Pellegrini M; Forgione RN; Rucci P
    Am J Addict; 2011; 20(2):179-80. PubMed ID: 21314764
    [No Abstract]   [Full Text] [Related]  

  • 2. Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study.
    Meini M; Moncini M; Cecconi D; Cellesi V; Biasci L; Simoni G; Ameglio M; Pellegrini M; Forgione RN; Rucci P
    Curr Pharm Des; 2011; 17(14):1376-83. PubMed ID: 21524261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of aripiprazole-related tardive akathisia and its treatment with ropinirole.
    Hettema JM; Ross DE
    J Clin Psychiatry; 2007 Nov; 68(11):1814-5. PubMed ID: 18052582
    [No Abstract]   [Full Text] [Related]  

  • 4. Aripiprazole as a dopamine partial agonist: positive and negative effects.
    Glick ID; Duggal V; Hodulik C
    J Clin Psychopharmacol; 2006 Feb; 26(1):101-3. PubMed ID: 16415723
    [No Abstract]   [Full Text] [Related]  

  • 5. Aripiprazole: does partial dopaminergic agonism translate into clinical benefits?
    Crismon ML; DeLeon A; Miller AL
    Ann Pharmacother; 2003 May; 37(5):738-40. PubMed ID: 12708954
    [No Abstract]   [Full Text] [Related]  

  • 6. An open-label study of aripiprazole in nonschizophrenic crack-dependent patients.
    Vorspan F; Bellais L; Keijzer L; Lépine JP
    J Clin Psychopharmacol; 2008 Oct; 28(5):570-2. PubMed ID: 18794657
    [No Abstract]   [Full Text] [Related]  

  • 7. The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out.
    Citrome L
    Int J Clin Pract; 2015 Nov; 69(11):1211-20. PubMed ID: 26477545
    [No Abstract]   [Full Text] [Related]  

  • 8. Worsening of psychosis in a 30 year old man with undifferentiated schizophrenia.
    Ahuja N; Lloyd AJ
    Ann Clin Psychiatry; 2008; 20(2):113-4. PubMed ID: 18568584
    [No Abstract]   [Full Text] [Related]  

  • 9. Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia.
    Gründer G; Kungel M; Ebrecht M; Göröcs T; Modell S
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S21-5. PubMed ID: 16508892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hiccups associated with switching from olanzapine to aripiprazole in a patient with paranoid schizophrenia.
    Hori H; Nakamura J
    Clin Neuropharmacol; 2014; 37(3):88-9. PubMed ID: 24824665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do dopamine partial agonists have partial efficacy as antipsychotics?
    Stahl SM
    CNS Spectr; 2008 Apr; 13(4):279-82. PubMed ID: 18408646
    [No Abstract]   [Full Text] [Related]  

  • 12. Aripiprazole-induced tardive dyskinesia: the role of tamoxifen.
    Evcimen YA; Evcimen H; Holland J
    Am J Psychiatry; 2007 Sep; 164(9):1436-7. PubMed ID: 17728431
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma.
    Freeman B; Levy W; Gorman JM
    J Psychiatr Pract; 2007 Mar; 13(2):120-4. PubMed ID: 17414690
    [No Abstract]   [Full Text] [Related]  

  • 14. Aripiprazole-induced extrapyramidal side effects in a patient with schizoaffective disorder.
    Ziegenbein M; Sieberer M; Calliess IT; Kropp S
    Aust N Z J Psychiatry; 2006 Feb; 40(2):194-5. PubMed ID: 16476141
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of alternating hemiplegia of childhood with aripiprazole.
    Haffejee S; Santosh PJ
    Dev Med Child Neurol; 2009 Jan; 51(1):74-7. PubMed ID: 19087103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance.
    Stoops WW; Lile JA; Lofwall MR; Rush CR
    Am J Drug Alcohol Abuse; 2007; 33(6):769-76. PubMed ID: 17994473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole in children and adolescents with conduct disorder: a single-center, open-label study.
    Ercan ES; Uysal T; Ercan E; Akyol Ardic U
    Pharmacopsychiatry; 2012 Jan; 45(1):13-9. PubMed ID: 21993869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole in the treatment of Alzheimer's disease.
    De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
    Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new atypical antipsychotic with partial dopamine agonist effect (aripiprazole)].
    Kerpel-Fronius S; Lóránt M
    Neuropsychopharmacol Hung; 2004 Dec; 6(4):177-84. PubMed ID: 15825673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manic episode during treatment with aripiprazole.
    Padala PR; Wengel SP; Petty F
    Am J Psychiatry; 2007 Jan; 164(1):172-3. PubMed ID: 17202565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.